Skip to main content
FinSpry Logo
FinSpry
MNMD logo
MNMD
(NASDAQ)
Definium Therapeutics, Inc.
$18.09-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Definium Therapeutics (MNMD) Stock Price & Financial Analysis

Definium Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.05 - $18.74
52-Week High$19.62
52-Week Low$4.70
Open$18.29
Volume1.47M
Average Volume (3M)1.47M
Market Cap1.55B
Shares Outstanding85.89M
Price to Book (P/B)11.90
EV/EBITDA-9.64
50-Day MA$16.78
200-Day MA$11.97
52-Week Change179.60%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Definium Therapeutics

What is the current stock price for MNMD?

As of the latest trading session, MNMD stock trades at $18.09. The 52-week range is $4.70–$19.62, with a day range of $18.05–$18.74.

What is the P/E ratio for MNMD?

The P/E ratio (Price-to-Earnings) for MNMD is shown in the Key Statistics section. This valuation metric helps compare Definium Therapeutics, Inc. to industry peers.

Does MNMD pay dividends?

Definium Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MNMD?

Analyst ratings and recommendations for MNMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MNMD?

Definium Therapeutics's market capitalization is $1.55B, classifying it as a small-cap company. Definium Therapeutics operates in the Healthcare sector within the Biotechnology industry.